BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/06/2023

FDA Clears Path for Generic Buspirone Hydrochloride Capsules

The FDA has determined that BUSPAR capsules in various strengths were not withdrawn due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →